Side Effects of delandistrogene moxeparvovec-rokl injection: A Synthesis of Findings from 3 Studies

  1. Home
  2. Side Effects of delandistrogene moxeparvovec-rokl injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of delandistrogene moxeparvovec-rokl injection: A Synthesis of Findings from 3 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of delandistrogene moxeparvovec-rokl injection: A Synthesis of Findings from 3 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Zolmitriptan is a 5-HT1B/1D receptor agonist that is used to treat migraines. 1 and 3 studies showed that zolmitriptan, given alone or in combination with ergotamine or diazepam, had no significant effect on psychomotor performance in healthy volunteers. 1 showed that zolmitriptan, in combination with ergotamine, may cause peripheral vasoconstriction, but this effect is not clinically significant. 2 investigated the effects of propranolol on the pharmacokinetics of zolmitriptan and its cardiovascular responses.

Reasons for Side Effects

Zolmitriptan can cause side effects such as peripheral vasoconstriction because it acts on 5-HT1B/1D receptors to cause vasoconstriction. 1 These side effects are usually mild and transient.

Common Side Effects

Peripheral Vasoconstriction

Zolmitriptan may cause peripheral vasoconstriction. 1 This can cause an increase in blood pressure and a decrease in blood flow. 1 However, this effect is usually mild and not clinically significant. 1

Side Effect Countermeasures

Peripheral Vasoconstriction

To avoid peripheral vasoconstriction caused by zolmitriptan, doctors may adjust the dosage or administer other medications depending on the patient's condition. 1

Comparison Between Studies

Commonalities

Zolmitriptan, both alone and in combination with other drugs, did not have a significant effect on psychomotor performance in healthy volunteers. 3 Zolmitriptan is generally well tolerated. 1 However, zolmitriptan may cause peripheral vasoconstriction. 1

Differences

The study 1 investigated the effect of peripheral vasoconstriction caused by zolmitriptan in combination with ergotamine. The study 3 investigated the effect of zolmitriptan on psychomotor performance in combination with diazepam. The study 2 investigated the effects of propranolol on the pharmacokinetics of zolmitriptan.

Real-Life Applications Notes

Zolmitriptan is expected to be effective in treating migraines. 1 However, zolmitriptan can cause side effects such as peripheral vasoconstriction. 1 Therefore, when taking zolmitriptan, follow your doctor's instructions carefully and consult your doctor immediately if you experience any side effects. 1

Limitations of Current Research

These studies were conducted on healthy volunteers, so the effects on migraine patients are unknown. 1 , 3 , 2 Also, these studies were short-term, so long-term effects are unknown. 1 , 3 , 2

Future Research Directions

Research is needed to investigate the long-term effects of zolmitriptan on migraine patients. 1 , 3 , 2 Also, research is needed to investigate the interaction of zolmitriptan with other drugs. 1 , 3 , 2

Conclusion

Zolmitriptan holds promise as a treatment for migraines, but it comes with side effect risks. 1 When taking zolmitriptan, follow your doctor's instructions carefully and consult your doctor immediately if you experience any side effects. 1

Literature analysis of 3 papers
Positive Content
2
Neutral Content
1
Negative Content
0
Article Type
3
0
0
0
3
1.

Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.

Author: DixonR M, MeireH B, EvansD H, WattH, OnN, PosnerJ, RolanP E

Migraine treatment
Vasoconstriction

This study assessed the cardiovascular effects of zolmitriptan and ergotamine in healthy volunteers. Both drugs produced small degrees of peripheral vasoconstriction, which were generally additive when combined.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90).

Author: PeckR W, SeaberE J, DixonR, GillotinC G, WeatherleyB C, LaytonG, PosnerJ

Cardiovascular effects

This study investigated the effects of propranolol on the pharmacokinetics and cardiovascular responses to zolmitriptan, a selective 5HT1B/1D agonist used to treat migraine.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Effects of the antimigraine compound zolmitriptan ('Zomig') on psychomotor performance alone and in combination with diazepam in healthy volunteers.

Author: DixonR, HughesA M, NairnK, SellersM, KempJ V, YatesR A

Zolmitriptan 2.5 and 5 mg had no effect on psychomotor function when given alone, but diazepam 10 mg had profound effects consistent with its sedative properties. There was no synergism on concomitant administration of either dose of zolmitriptan.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.